Dr. John Cush RheumNow
7 years 7 months ago
Nurses Health Study had 1528 incident #RA cases. Current smoking increased risk of seropositive (not Seronegative) RA (HR 1.47). Smoking cessation >10, >20, >30 yrs ago assoc w/ decreasing risk of seropos. RA, but risk still remains > 30 yrs (HR 1.30) https://t.co/1CsIcXtJ1I
Individuals who quit smoking and maintained their nonsmoking status over a long duration of time had a decreased risk of developing seropositive rheumatoid arthritis (RA), an analysis of two large prospective cohorts found.
Dr. John Cush RheumNow
7 years 7 months ago
Prospective cohort study of 93 Systemic sclerosis patients with ILD; 2/3 had diffuse SSc. Half had PH diagnosis w/in 7 yrs of SSc onset, 83% Rx with ILD therapy, 83% Rx for PH. Survival rate for SSc-ILD and PH at 3 years after PH diagnosis was 91%. https://t.co/ZmOmWutwxq
Dr. John Cush RheumNow
7 years 7 months ago
8.9% of systemic sclerosis pts were ANCA+, denoting a subset with increased risk of ILD (44.8% vs 21.8%, p < 0.001) and pulmonary embolism (8.6% vs 3.0%) in SSc. ANCA should be tested in SSc, as it identifies individuals with worse prognosis https://t.co/WhlEpxFdIG
Dr. John Cush RheumNow
7 years 7 months ago
QD Clinic - New Changes to Gout Guidelines. Lessons from the clinic - a noncompliant gout patient needs to restart his gout drugs, what to do with febuxostat? https://t.co/XwaUewBjWS via @YouTube
Dr. John Cush RheumNow
7 years 7 months ago
ERRATA: "How to Handle Latex Allergies and Biologics" - has been corrected to show that the Cimzia PFS DOES contain 7% of a plastic derived from natural rubber latex. Latex- sensitive patients should be advised to handle the needle shield with caution. https://t.co/ThLns4C5Jt
Dr. John Cush RheumNow
7 years 7 months ago
Among 548 pts referred to academic pain center & treated for back pain, 42% met fibromyalgia criteria. FM+ pts were more likely to be younger, unemployed, w/ greater pain severity, more neuropathic pain, depression, anxiety & lower physical function https://t.co/gse5CDnJ13
QD Clinic - New Changes to Gout Guidelines
A Gout patient needs to restart his gout therapies
A multidisciplinary Canadian task force has developed guidelines for vaccination in patients receiving immunosuppressive therapies, based on the evidence that immunosuppressive use in immune-mediated disease may be associated with an elevated risk of infections.
Dr. John Cush RheumNow
7 years 8 months ago
Taiwanese insurance claims data study shows that Sjogrens syndrome patients (n=13398) have increased risk of osteonecrosis of jaw compared to 54K controls (0.08%vs0.03%, p=0.017) & also bisphosphonate ONJ (adjusted HR=7.9, p<0.001). https://t.co/qQSV16muNN
The U.S. Food and Drug Administration (FDA) has reviewed data from the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial and concluded there is an increased risk of death with Uloric (febuxostat) compared with allopurinol, and has added this as a boxed warning to the drug’s product label.
Dr. John Cush RheumNow
7 years 8 months ago
JAMA reports from 2005-2015 PCP density in USA decreased from 46.6 to 41.4 per 100 000, with greater losses in rural areas. Every 10 PCP increase per 100K was assoc w/ added 51 day survival; every 10 specialists per 100k correlated with 19d incr survival https://t.co/81TRwFzOnH
Johns Hopkins Rheumatology jhrheumatology
7 years 8 months ago
The Johns Hopkins Myositis Center is proud to announce the launch of the Peter Frampton Myositis Research Fund.
https://t.co/SAVf1AEdqO
Join @peterframpton and our Myositis Center team as we work to improve the lives of those impacted by #myositis https://t.co/BjOOaHYuJq
Dr. John Cush RheumNow
7 years 8 months ago
QD Clinic Week 6 Podcast - case based lessons from the real world. Discusion of Pregnancy Rules, Optimizing MTX, Changing DMARDs, Stopping Anakinra in Still's, NP decisions. Listen on iTUNES or Here https://t.co/61KO2jKxJp
Dr. John Cush RheumNow
7 years 8 months ago
RheumNow Podcast is up! Discussions of Death rates, Jt. Surgeries, Lupus microbiome & activity, JIA outcomes, Tofacitinib Warnings, 25 Yr Hip replacements. Watch here https://t.co/tYS6WDV3in or Listen to the Podcast on iTunes or soundcloud https://t.co/NkXngajhUB
